Crescent Capital BDC (NASDAQ:CCAP) Price Target Lowered to $14.00 at LADENBURG THALM/SH SH

Crescent Capital BDC (NASDAQ:CCAP) had its price target reduced by analysts at LADENBURG THALM/SH SH from $15.00 to $14.00 in a research note issued to investors on Wednesday,Benzinga reports. The firm presently has a “buy” rating on the stock. LADENBURG THALM/SH SH’s price objective would suggest a potential upside of 25.45% from the stock’s previous close.

CCAP has been the subject of several other research reports. Zacks Research raised shares of Crescent Capital BDC from a “strong sell” rating to a “hold” rating in a research report on Tuesday, July 21st. Oppenheimer lowered shares of Crescent Capital BDC from an “outperform” rating to a “market perform” rating and reduced their target price for the company from $19.00 to $16.00 in a report on Friday, May 15th. Wall Street Zen cut shares of Crescent Capital BDC from a “hold” rating to a “sell” rating in a research report on Saturday, July 25th. Keefe, Bruyette & Woods lowered their price target on Crescent Capital BDC from $15.00 to $13.00 and set an “outperform” rating for the company in a report on Tuesday, June 16th. Finally, Wells Fargo & Company cut their price objective on Crescent Capital BDC from $12.00 to $11.00 and set an “equal weight” rating on the stock in a research report on Wednesday. Two research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. According to data from MarketBeat, the company has an average rating of “Hold” and an average price target of $13.30.

Crescent Capital BDC Trading Down 2.4%

CCAP traded down $0.28 on Wednesday, reaching $11.16. 147,676 shares of the company’s stock were exchanged, compared to its average volume of 222,311. The company’s 50 day moving average is $11.16 and its 200-day moving average is $12.38. The company has a market cap of $411.20 million, a price-to-earnings ratio of -124.00 and a beta of 0.52. Crescent Capital BDC has a twelve month low of $10.64 and a twelve month high of $16.03. The company has a debt-to-equity ratio of 1.35, a quick ratio of 1.53 and a current ratio of 1.53.

Crescent Capital BDC (NASDAQ:CCAP) last posted its quarterly earnings results on Monday, August 10th. The company reported $0.36 EPS for the quarter, missing the consensus estimate of $0.37 by ($0.01). The business had revenue of $5.12 million during the quarter, compared to analysts’ expectations of $37.12 million. Crescent Capital BDC had a negative net margin of 2.02% and a positive return on equity of 8.88%. Equities analysts predict that Crescent Capital BDC will post 1.38 earnings per share for the current year.

Insider Activity at Crescent Capital BDC

In other news, President Henry Chung bought 4,500 shares of Crescent Capital BDC stock in a transaction dated Thursday, May 21st. The shares were acquired at an average cost of $11.45 per share, with a total value of $51,525.00. Following the completion of the transaction, the president owned 20,722 shares in the company, valued at approximately $237,266.90. This trade represents a 27.74% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Jason Breaux bought 5,000 shares of the firm’s stock in a transaction dated Wednesday, May 20th. The stock was purchased at an average price of $11.19 per share, with a total value of $55,950.00. Following the completion of the purchase, the chief executive officer directly owned 52,636 shares of the company’s stock, valued at approximately $588,996.84. This trade represents a 10.50% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. 1.23% of the stock is owned by company insiders.

Institutional Investors Weigh In On Crescent Capital BDC

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Northwestern Mutual Wealth Management Co. purchased a new position in Crescent Capital BDC in the 4th quarter valued at about $27,000. Rockefeller Capital Management L.P. acquired a new position in shares of Crescent Capital BDC in the fourth quarter worth about $35,000. VPR Management LLC lifted its stake in shares of Crescent Capital BDC by 150.0% in the third quarter. VPR Management LLC now owns 5,000 shares of the company’s stock worth $71,000 after acquiring an additional 3,000 shares in the last quarter. Beaumont Financial Advisors LLC purchased a new position in Crescent Capital BDC in the first quarter valued at about $127,000. Finally, Permanens Capital L.P. purchased a new position in Crescent Capital BDC in the third quarter valued at about $147,000. Hedge funds and other institutional investors own 49.46% of the company’s stock.

Key Headlines Impacting Crescent Capital BDC

Here are the key news stories impacting Crescent Capital BDC this week:

• Positive Sentiment: Crescent Capital BDC declared a third-quarter base dividend of $0.34 per share and a $0.03 special dividend. The base payout implies an annualized yield of approximately 11.9%, which may support income-focused demand for CCAP. The ex-dividend date is September 30, with payment scheduled for October 15. Crescent Capital BDC declares dividend and special dividend
• Neutral Sentiment: Management expects leverage to return to its target range during the second half of 2026 while maintaining the $0.34 base dividend. The outlook provides some reassurance on capital management, although leverage normalization remains dependent on execution and portfolio conditions. Crescent Capital BDC leverage outlook
• Negative Sentiment: Wells Fargo lowered its price target for CCAP to $11 from $12 and assigned an “equal weight” rating, indicating limited upside and roughly 1.5% downside from the recent share price. The reduced target reflects a more cautious valuation outlook. Wells Fargo price target report
• Negative Sentiment: Crescent Capital BDC reported second-quarter earnings of $0.36 per share, below the $0.37 consensus estimate and down from $0.46 a year earlier. Reported revenue of $5.12 million was also substantially below the $37.12 million consensus figure, adding to concerns about operating performance. Crescent Capital BDC misses second-quarter estimates

Crescent Capital BDC Company Profile

Crescent Capital BDC, Inc is a closed-end, externally managed business development company that provides flexible financing solutions to middle market companies in the United States. Trading on the Nasdaq under the ticker CCAP, the firm offers investors exposure to a diversified portfolio of debt and equity instruments, targeting businesses with attractive risk-adjusted return profiles. Its primary objective is to generate current income through interest payments and potential capital appreciation via selective equity co-investments.

The company’s investment strategy emphasizes senior secured loans, unsecured second-lien loans, mezzanine debt, as well as preferred and common equity co-investments.